Price$524.58+16.13 (+3.17%)
01:30 PM07:45 PM
News · 26 weeks86-50%
2026-01-112026-07-05
Mix3690d
- Insider16(44%)
- SEC Filings5(14%)
- Other6(17%)
- Analyst5(14%)
- Earnings2(6%)
- Dividends2(6%)
Latest news
25 items- PRThermo Fisher Scientific Announces Quarterly DividendThermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on October 15, 2026, to shareholders of record as of September 15, 2026. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the
- PRThermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2026 before the market opens on Thursday, July 23, 2026, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on the "Investors" section of our website, www.thermofisher.com. You can access the conference call by dialing (833) 461-5787 within the U.S. or +1 (585) 542-9983 outside the U.S. The access code is 835035800. The earnings press release and related information can also be found in that
- INSIDERSEC Form 4 filed by Director Sperling Scott M4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERSEC Form 4 filed by Director Keith R. Alexandra4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERSEC Form 4 filed by Director Weisler Dion J4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERSEC Form 4 filed by Director Lynch Karen S4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERSEC Form 4 filed by Director Johnson Jennifer M4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- ANALYSTBernstein resumed coverage on Thermo Fisher with a new price targetBernstein resumed coverage of Thermo Fisher with a rating of Mkt Perform and set a new price target of $520.00
- SECSEC Form 11-K filed by Thermo Fisher Scientific Inc11-K - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
- ANALYSTPiper Sandler initiated coverage on Thermo Fisher with a new price targetPiper Sandler initiated coverage of Thermo Fisher with a rating of Neutral and set a new price target of $510.00
- ANALYSTThermo Fisher downgraded by HSBC Securities with a new price targetHSBC Securities downgraded Thermo Fisher from Buy to Hold and set a new price target of $540.00
- ANALYSTWolfe Research resumed coverage on Thermo Fisher with a new price targetWolfe Research resumed coverage of Thermo Fisher with a rating of Outperform and set a new price target of $535.00
- SECSEC Form SD filed by Thermo Fisher Scientific IncSD - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
- PRThermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New TherapiesNew mass spectrometry platforms, combined with AI-driven analytics and scalable proteomics solutions, help scientists turn complex biology into actionable insights across research and drug development Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the Thermo Scientific™ Orbitrap™ Tribrid™ Apex and Thermo Scientific™ Orbitrap™ Excedion™ mass spectrometers will be showcased at the American Society for Mass Spectrometry (ASMS) Conference. As scientific discovery expands into more complex applications—from advanced proteomics and multiomics to biologics and genetic medicines—researchers and drug developers face increasing pressure to generate hi
- SECThermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
- INSIDERDirector Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERDirector Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERDirector Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERDirector Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERDirector Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERDirector Johnson Jennifer M was granted 499 shares, increasing direct ownership by 55% to 1,403 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERDirector Jacks Tyler was granted 499 shares, increasing direct ownership by 6% to 9,462 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERDirector Harris C Martin was granted 499 shares, increasing direct ownership by 6% to 9,532 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERDirector Chandy Ruby R was granted 499 shares, increasing direct ownership by 17% to 3,463 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERDirector Chai Nelson was granted 499 shares, increasing direct ownership by 3% to 15,316 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
TMO FAQ
7 questionsWhat does Thermo Fisher Scientific Inc do?
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in...Where does TMO stock trade?
Thermo Fisher Scientific Inc (TMO) is listed on NYSE.What sector and industry is TMO in?
Thermo Fisher Scientific Inc operates in the Industrials sector, Industrial Machinery/Components industry.Does TMO pay a dividend?
TMO's most recent ex-dividend date was 2026-06-15 with a cash dividend of $0.47 per share. No future ex-date is on file yet.What are analysts saying about TMO?
Thermo Fisher Scientific Inc has had 8 recent analyst actions on file. The most recent action was from Bernstein: Mkt Perform on 2026-06-26.What companies are similar to TMO?
Notable peers in the same industry include ASML (ASML Holding N.V. New York Registry Shares), LRCX (Lam Research Corporation), DE (Deere & Company), ETN (Eaton Corporation PLC), DHR (Danaher Corporation). Compare TMO side-by-side with any of them on Quantisnow.How can I track TMO on Quantisnow?
Quantisnow aggregates Thermo Fisher Scientific Inc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TMO to receive live email and push alerts on every new disclosure.